- Home
- GCEngine platform
- Solution
- Partners & Collaborations
- Company
Precise chemical modifications at single nucleotide positions within tRNA determine translation accuracy, speed, and structural stability. Specific sites—such as the wobble base (U34), the anticodon-adjacent region (G37/A37), and the T-loop (U55/A58)—play decisive roles in codon decoding, ribosome interaction, and tRNA quality control.
At the GCEngine platform, we offer tRNA site-specific modification services that enable targeted installation or replacement of chemical marks, allowing researchers to reconstruct natural modification networks or engineer synthetic functionalities (e.g., click-labeling handles or photoreactive groups) and, when paired with orthogonal aaRS/tRNA systems, support ncAA-related workflows.
tRNAs are among the most extensively modified biomolecules, typically carrying more than a dozen chemical modifications that are installed at precise nucleotide positions. Each modification contributes uniquely to tRNA's biological performance—stabilizing folding, optimizing codon–anticodon pairing, and regulating the decoding rate during translation.
Among these, site-specific modifications are particularly critical. For instance, modifications at position 34 (the wobble base) fine-tune decoding flexibility and codon bias; position 37 modifications adjacent to the anticodon prevent frameshifting and maintain reading-frame stability; and T-loop modifications (U55, A58) reinforce tertiary folding and protect tRNAs from degradation.
Modern biochemical and synthetic methods now allow controlled editing of these individual positions, enabling scientists to reconstruct or reprogram translation machinery with single-nucleotide precision. Such site-defined tRNAs form the foundation of genetic code expansion systems, mitochondrial therapy research, and targeted translational regulation models.
Fig.1 Modifications of the tRNA anticodon loop. (Fages-Lartaud, M., et al., 2022)
We partner with you to design site-specific tRNA modifications aligned with your target codon, host system and desired function (e.g., orthogonal amino acid incorporation, click-chemistry labeling, translational speed modulation). Utilizing enzymatic, chemo-enzymatic or semisynthetic strategies (depending on the position and chemistry), we create and validate tRNAs bearing a single defined modification or combination thereof. Each modification site presents unique structural constraints and biological outcomes; therefore, selecting the most suitable method requires balancing enzyme specificity, chemical feasibility, and downstream application goals. The GCEngine platform evaluates these parameters to design the most effective modification route.
| Target Site (Position) | Representative Modification(s) | Preferred Strategy | Core Enzyme or Chemistry | Typical Application |
| U34 (Wobble Position) | mcm⁵U, mcm⁵s²U, Q, I, τm⁵U | Enzymatic (ELP3/CTU1-2 or TGT) or chemo-enzymatic SAM-analog editing | ELP complex, CTU1/CTU2, TGT, ADAT | Decoding bias and wobble flexibility; A-site selection fidelity; mitochondrial τm⁵U34 for mt-tRNA decoding contexts |
| G37/A37 (Anticodon-Adjacent) | yW37, t⁶A37, m¹G37 | Multi-enzyme cascade or semisynthetic ligation | TYW1–4, KEOPS, TRMT5 | Reading-frame maintenance and frameshift suppression; anticodon stabilization. |
| Ψ55 (T-Loop) | Ψ55 | Direct enzymatic pseudouridylation | TruB/PUS family | Tertiary stabilization; effects on tRNA quality control. |
| A58 (T-Arm) | m¹A58 | Enzymatic or semisynthetic duplex assembly | TRMT6/61A | Prevents initiator tRNA degradation, supports initiation |
| C32/C34 (2'-O-Methylation) | Cm32, Nm34 | Enzymatic 2'-O-methyltransferase reactions or SAM-analog strategies | FTSJ1/TRM7 | Neural-specific translation and codon preference tuning |
| C38 (Anticodon Stem) | m⁵C38 | Enzymatic methyltransferase reaction | DNMT2 | Stress-resistance and tRNA cleavage protection |
| m⁷G46 (Variable Loop) | m⁷G46 | Enzymatic or in vitro reconstitution | METTL1/WDR4 | Associated with enhanced translation and reduced ribosome stalling in specific contexts |
| m³C32 (Neuronal) | m³C32 | Dual-enzyme expression or chemo-enzymatic | DALRD3 + METTL2A/2B | Neural function and fidelity maintenance |
| τm⁵U34 (Mitochondrial) | τm⁵U34 | Enzymatic (MTO1/GTPBP3) or semisynthetic ligation | MTO1, GTPBP3 | Can rescue UUG decoding defects in disease-associated mt-tRNA variants. |
Site-specific tRNA editing does not by itself create orthogonal translation or enable ncAA incorporation. When paired with orthogonal aaRS/tRNA systems, these edits can support genetic-code-expansion studies by tuning decoding context, fidelity, or stability. Contact us to design a position-defined modification strategy for your translational model or disease mechanism study.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.